How can doctors discuss CLL treatment options with patients?
Updates to the iwCLL guidelines
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Is effective management of CLL as a chronic disease as good as a '"cure"?
The combination of BGB-3111 and obinutuzumab for follicular lymphoma: promising preliminary results